SAN DIEGO, April 6, 2010 /PRNewswire via COMTEX/ --BioMed Realty Trust, Inc. (NYSE: BMR), The Leading Provider of Real Estate to the Life Science Industry(R), announced today that it will be hosting its Investor Day 2010 for investors and equity analysts at the company's The Landmark at Eastview campus in Tarrytown, New York on May 11, 2010 from 11:30 a.m. to 3:00 p.m. Eastern Time. The Investor Day agenda will feature presentations by BioMed's executives and a tour of the exceptional life science facilities at The Landmark.
"We chose The Landmark campus as the site for our Investor Day 2010 in recognition of the tremendous achievements at The Landmark in 2009 as a result of BioMed's steady focus on executing our robust business model," said Alan D. Gold, BioMed's Chairman and Chief Executive Officer. "Over the past year, our development team delivered over 360,000 square feet of new, state-of-the-art laboratory and office space comprised of three new buildings 100% leased to Regeneron Pharmaceuticals, which now serve as their corporate headquarters and primary research facilities. Our best-in-class team of leasing professionals executed over 636,000 square feet of space, adding to a strong tenant roster at the campus that includes Regeneron, Progenics Pharmaceuticals and Momentive Performance Materials. In addition, we purchased additional land parcels totaling approximately 36 acres, increasing the size of the campus to approximately 150 acres and positioning ourselves to capitalize on future development opportunities."
"As a result of these exceptional cross-departmental efforts, we entered 2010 with the 1.1 million square foot campus over 90% leased," Mr. Gold added. "We are very excited about the future for life science, especially at The Landmark. We look forward to hosting our Investor Day 2010 at the campus and continuing to support the life science endeavors in Westchester County and New York State with world-class research facilities in 2010 and beyond."
Attendance for this event is by invitation only and space is limited. A live audio webcast of the company's presentation will be available to interested parties through a link on BioMed's website at http://www.biomedrealty.com/.
About BioMed Realty Trust
BioMed Realty Trust, Inc. is a real estate investment trust (REIT) focused on Providing Real Estate to the Life Science Industry(R). The company's tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. BioMed owns or has interests in 71 properties, representing 114 buildings with approximately 10.8 million rentable square feet. The company's properties are located predominantly in the major U.S. life science markets of Boston, San Diego, San Francisco, Seattle, Maryland, Pennsylvania and New York/New Jersey, which have well-established reputations as centers for scientific research. Additional information is available at http://www.biomedrealty.com/.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 based on current expectations, forecasts and assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially. These risks and uncertainties include, without limitation: general risks affecting the real estate industry (including, without limitation, the inability to enter into or renew leases, dependence on tenants' financial condition, and competition from other developers, owners and operators of real estate); adverse economic or real estate developments in the life science industry or the company's target markets; risks associated with the availability and terms of financing, the use of debt to fund acquisitions and developments, and the ability to refinance indebtedness as it comes due; failure to manage effectively the company's growth and expansion into new markets, or to complete or integrate acquisitions and developments successfully; risks and uncertainties affecting property development and construction; risks associated with downturns in the national and local economies, increases in interest rates, and volatility in the securities markets; potential liability for uninsured losses and environmental contamination; risks associated with the company's potential failure to qualify as a REIT under the Internal Revenue Code of 1986, as amended, and possible adverse changes in tax and environmental laws; and risks associated with the company's dependence on key personnel whose continued service is not guaranteed. For a further list and description of such risks and uncertainties, see the reports filed by the company with the Securities and Exchange Commission, including the company's most recent annual report on Form 10-K and quarterly reports on Form 10-Q. The company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
SOURCE BioMed Realty Trust, Inc.